About CryoCap cells
CryoCap cells is a company based in Paris (France) founded in 2013. CryoCap cells has raised $1.88 million across 1 funding round from investors including Seventure Partners. CryoCap cells offers products and services including F°Low Software, High Pressure Freezer, and CryoCapsule. CryoCap cells operates in a competitive market with competitors including Evosep, Ovizio, Pressure BioSciences, Curiox and inveox, among others.
- Headquarter Paris, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cryocapcell.com
- Social LinkedIn X
- Legal Name Cryocapcell Sas
- Total Equity Funding$1.88M (USD)
in 1 rounds
- Latest Funding Round$1.88M (USD), Seed
Jan 2017
- Investors
Products & Services of CryoCap cells
CryoCap cells offers a comprehensive portfolio of products and services, including F°Low Software, High Pressure Freezer, and CryoCapsule.
Software for managing samples in microscopy workflows.
Device for rapid freezing of biological samples.
Tools for handling and protecting samples in electron microscopy.
Funding Insights of CryoCap cells
CryoCap cells has successfully raised a total of $1.88M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.88 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.88M
- Total Rounds 1
- Last Round Seed — $1.88M
- First Round $1.88M
(Jan 2017)
- Investors Count 1
All 1 funding rounds of CryoCap cells with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $1.88M | Seed | – | – |
1 investors in total: 1 institutional.
Investors in CryoCap cells
CryoCap cells has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Seventure Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US | – | seventure.fr | Paris, France |
Investor details for CryoCap cells
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CryoCap cells
7 people are tracked at CryoCap cells (1 in leadership, 6 in board & advisors).
| Name | Role | Group |
|---|---|---|
Jérôme Heiligenstein | CEO | Leadership |
Martin Belle | Board Member | Board & advisors |
Frederic Eyraud | Advisory Board Member | Board & advisors |
Xavier Heiligenstein | Board Member | Board & advisors |
Vincent Muczynski | Advisory Board Member | Board & advisors |
Philippe Tramoy | Advisory Board Member | Board & advisors |
Erfane Arwani | Advisory Board Member | Board & advisors |
Complete people profiles for CryoCap cells
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CryoCap cells
2 dated milestones of CryoCap cells across 4 years, from founding to its latest funding, stage changes and deals.
- Founded CryoCap cells is founded.
- Funding First funding round of $1.9M.
Competitors of CryoCap cells
CryoCap cells operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evosep, Ovizio, Pressure BioSciences, Curiox and inveox, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evosep.com | 2016 | Odense, Denmark | $48.78M | 62 | Solutions for clinical proteomics sample preparation are developed. | |
| ovizio.com | 2009 | Brussels, Belgium | $9.1M | 16 | Imaging systems and AI software for microscopes are developed. | |
| pressurebiosciences.com | 1978 | Easton, United States | – | 15 | Biomolecular reactions are controlled via pressure cycling technology. | |
| curiox.com | 2007 | Singapore | $30M | – | Wall-less plates and washers are developed for automated cell-based assays. | |
| inveox.com | 2017 | Munich, Germany | $25.81M | – | Automated solutions for biopsy sample preparation in laboratories are provided. | |
| annaida.ch | 2018 | Lausanne, Switzerland | $1.06M | – | Magnetic resonance sensors for microscopic studies are developed. | |
| acousort.com | 2010 | Lund, Sweden | $213,996 | – | Microfluidic acoustofluidics technology for cell separation is developed. | |
| inso.bio | 2020 | Ithaca, United States | $2.45M | – | Microfluidic automated devices for cellular sample preparation are developed. |
Detailed competitors of CryoCap cells
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to CryoCap cells
10 companies that operate in the same segment as CryoCap cells (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CryoCap cells
CryoCap cells was founded in 2013 and raised its 1st funding round 4 years after it was founded.
CryoCap cells is headquartered in Paris, France.
CryoCap cells is a funded company, having raised a total of $1.88M across 1 funding round to date. The company's 1st funding round was a Seed of $1.88M, raised on Jan 2017.
CryoCap Cells was founded in 2013 in Paris, France, and operates within the microscopy sector. Products for correlative light and electron microscopy are developed, focusing on sample preparation techniques. The portfolio includes the Cryocapsule for high-pressure vitrification, the HPM010 kit for loading into high-pressure freezers, and the HPM Light µ with automated features for cryo capsules. Operations emphasize integration of live-cell imaging and immunolabeling processes.
CryoCap cells offers F°Low Software, High Pressure Freezer, and CryoCapsule.
CryoCap cells has 1 investor. Key investors include Seventure Partners.
CryoCap cells operates through Cryocapcell Sas.